Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Therapy
Higher serum hemoglobin levels may predict enhanced response to neoadjuvant chemotherapy
March 9th, 2006
Higher serum hemoglobin levels may predict an enhanced response for patients to neoadjuvant chemotherapy. A study group at the University of Turin reports, "The aim of this study was to evaluate the predictive value of pretreatment serum hemoglobin level (Hb) together with a series of clinical and pathological variables available before neoadjuvant chemotherapy in locally advanced squamous cervical cancer." "The influence on response to neoadjuvant chemotherapy of a series of pretreatment clinico-pathological features: hemoglobin level at diagnosis, age, parity, menopausal status, body mass index, clinical stage, tumor diameter, and nuclear grading...
Source: Women's Health Weekly (2006-03-09)
|
